Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.4
-288.56%
20%
—
16.48%
60%
—
5 Years
Score2.4
Net Growth-288.56%
Net Trend20%
Net Income Consistency—
Rev Growth16.48%
Rev Trend60%
Revenue Consistency—
VistaGen Therapeutics Inc fundamental performance
Between 2021 and 2026, revenue grew from $ 1M to $ 1M and net income went from -$ 17M to -$ 69M. Revenue increased in 3 of those 5 years; net income in 1.
Across VistaGen Therapeutics Inc's full reported history, from 2017 to 2026, revenue grew from $ 1M to $ 1M and net income went from -$ 10M to -$ 69M. Revenue increased in 56% of the years measured; net income in 33%.
VistaGen Therapeutics Inc currently holds a 5-year HDB Score of 2.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.26 | — |
1 Year2025-08-12 | $ 2.86 | -90.87% |
5 Years2021-08-12 | $ 82.50 | -99.68% |
10 Years2016-08-12 | $ 96.90 | -99.73% |
All Time2016-05-06 | $ 210.00 | -99.88% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2016-05-06 |
|---|---|---|---|---|---|
| Price | $ 0.26 | $ 2.86 | $ 82.50 | $ 96.90 | $ 210.00 |
| Return | — | -90.87% | -99.68% | -99.73% | -99.88% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1M | -$ 69M | $ 45M |
| 2025 | $ 486K | -$ 51M | $ 80M |
| 2024 | $ 1M | -$ 29M | $ 119M |
| 2023 | -$ 227.3K | -$ 59M | $ 16M |
| 2022 | $ 1M | -$ 47M | $ 68M |
| 2021 | $ 1M | -$ 17M | $ 103M |
| 2020 | $ 334K | -$ 20M | $ 1M |
| 2019 | $ 0.00 | -$ 24M | $ 13M |
| 2018 | $ 0.00 | -$ 14M | $ 10M |
| 2017 | $ 1M | -$ 10M | $ 2M |
Explore beyond VTGN
You're looking at VistaGen Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
